MPI Research And Shanghai Medicilon Form Shanghai-Based Joint Venture
This article was originally published in PharmAsia News
You may also be interested in...
China's CRO Industry Pulling Out All Stops In The Year Of The Tiger (Part 2 of 2)
[Editor's note: This is part two of a feature story on contract research organizations in China. Part one highlighted the evolution of the CRO industry, which has grown and changed to reflect the needs of both local and multinational pharma companies, which are increasingly outsourcing R&D projects to China. ]
China's CRO Industry Pulling Out All Stops In The Year Of The Tiger (Part 2 of 2)
[Editor's note: This is part two of a feature story on contract research organizations in China. Part one highlighted the evolution of the CRO industry, which has grown and changed to reflect the needs of both local and multinational pharma companies, which are increasingly outsourcing R&D projects to China. ]
Chinese Tigermed Forms CRO Partnerships In Korea, Russia
SHANGHAI - Tigermed Consulting, one of the leading contract research organizations in China, established partnerships with two leading CROs - OCT in Russia and LSK in Korea - the company announced Nov. 24